Blood markers of the renin‐angiotensin system and cognitive impairment: The Look AHEAD Study

Abstract

Background: The renin‐angiotensin system (RAS) has been proposed as a potential modifier of the development of Alzheimer's disease (AD). However, prospective studies are sparse.